Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hinge Health (HNGE) Liabilities and Shareholders Equity (2024 - 2026)

Hinge Health's Liabilities and Shareholders Equity history spans 2 years, with the latest figure at $744.8 million for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 10.62% to $744.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.9 billion, a 327.99% increase, with the full-year FY2025 number at $744.8 million, up 10.62% from a year prior.
  • Liabilities and Shareholders Equity hit $744.8 million in Q4 2025 for Hinge Health, down from $769.8 million in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for HNGE hit a ceiling of $769.8 million in Q3 2025 and a floor of $673.3 million in Q4 2024.